Metformin and the incidence of prostate cancer in patients with type 2 diabetes.

@article{Azoulay2011MetforminAT,
  title={Metformin and the incidence of prostate cancer in patients with type 2 diabetes.},
  author={Laurent Azoulay and Sophie Dell'aniello and Bruno Gagnon and Michael N. Pollak and Samy Suissa},
  journal={Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology},
  year={2011},
  volume={20 2},
  pages={337-44}
}
BACKGROUND Several in vitro studies have indicated that metformin may reduce the risk of prostate cancer; however, epidemiologic studies have been inconclusive. The objective of this study was to determine whether metformin decreases the risk of prostate cancer in patients with type 2 diabetes. METHODS A nested case-control analysis was conducted within a population-based cohort from the UK General Practice Research Database. The cohort included patients over the age of 40 who were prescribed… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 66 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 52 references

The Use of Pharmacoepidemiology to Study Beneficial Drug Effects

  • BL Strom, KL Melmon
  • Pharmacoepidemiology.Chichester: John Wiley 1994…
  • 2010

Similar Papers

Loading similar papers…